For decades, the biomedical research landscape has been dominated by a relatively small number of highly funded, high-profile laboratories. It is a system that tends to reward past success with future funding. But a newly proposed policy from the National Institutes of Health (NIH) could fundamentally reshape how federal research dollars flow through the U.S. university system.
In a recent Request for Information (NOT-OD-26-086), the NIH announced it is considering a strict cap on the number of simultaneous Research Project Grants (RPGs) an individual can hold as a Principal Investigator (PI) or Multi-Principal Investigator (MPI).
The NIH is currently weighing three scenarios: capping PIs at two, three, or four concurrent RPGs. The agency estimates that depending on where the cap is set, between $1.3 billion and $3.5 billion could be freed up to fund up to 5,230 additional investigators.
This is not just an administrative tweak. It is a strategic effort to decentralize funding. For large, legacy research institutions, it presents a significant compliance and talent-retention challenge. But for small and mid-sized universities, this proposed cap represents a generational opportunity to capture market share in federal biomedical research.
Why the NIH is Pushing for a Cap
The rationale behind the proposal is driven by data on scientific productivity. As the NIH notes in its RFI, studies consistently show diminishing marginal returns as grant funding for individual researchers increases. Beyond a certain point, larger, heavily funded research teams tend to produce less transformational work than smaller, more nimble teams.
There are also structural concerns. When a single PI manages five or six massive grants simultaneously, their ability to provide rigorous oversight and effectively mentor junior researchers inevitably drops.
By limiting concurrent RPGs, the NIH hopes to achieve three major goals:
- Broaden geographic and institutional distribution of federal funding.
- Increase support for early-stage and mid-career investigators who are often boxed out by entrenched mega-labs.
- Improve research rigor by ensuring PIs have the bandwidth to actively manage their active projects.
Opportunity for Small and Mid-Sized Universities
Currently, NIH funding is heavily concentrated. A small percentage of elite institutions and high-profile PIs command an outsized share of the agency’s $38 billion extramural research budget. In Fiscal Year 2025, over 10% of PIs held three or more simultaneous RPGs.
If implemented, the cap will force larger, more traditional research universities to make difficult choices. PIs who are over the cap will have to relinquish existing awards or transfer them to other investigators in order to accept new competing grants.
This creates a strategic opening for smaller and mid-sized research institutions.
With up to $3.5 billion potentially redistributed across the ecosystem, universities that have historically struggled to compete against elite mega-labs will suddenly find a more level playing field. The policy specifically aims to bring more talent into research careers across different geographic regions—meaning the NIH will be actively looking to fund high-quality science at institutions outside of the traditional biomedical hubs.
To capitalize on this shift, mid-sized universities should begin preparing now by:
- Sharpening Federal Funding Strategy: Institutions that will benefit the most will be the ones that identify high-probability funding opportunities aligned to their research concepts, institutional priorities, and the areas where their PIs are most competitive.
- Investing in Grant Development Support: With more funds available for new or mid-career PIs, universities need to ensure their faculty have the administrative and strategic support required to submit highly competitive R01s.
- Expanding Research Footprint: Many mid-sized universities do not need to build every capability in-house to compete more effectively. Specialized support and subject matter experts can help institutions pursue larger or more complex opportunities without waiting to build a full internal team.
- Fostering Collaborative Networks: The NIH values multi-disciplinary approaches. Smaller institutions can punch above their weight by forming strategic partnerships that complement internal strengths and make proposals more compelling to NIH reviewers.
How the Cap Would Be Implemented
The NIH is currently soliciting feedback on two implementation pathways:
- A phased reduction: Under this approach, an institution could not accept a competing renewal (Type 2) for an over-cap PI without relinquishing one of their existing grants. To accept a completely new grant (Type 1), the institution would have to relinquish enough existing grants to get the PI down to the cap limit immediately.
- A hard one-year deadline: A more abrupt option would require institutions to bring all PIs into compliance within one year of the policy’s effective date, either by relinquishing grants or transferring PI status to another researcher.
The public comment period for this RFI closes on August 3, 2026.
Strategic Positioning is Key
The proposed RPG cap, combined with the NIH’s previously announced limits on annual application submissions, signals a clear directive: the agency wants to fund a wider array of scientists, not just a wider array of projects from the same scientists.
EverGlade is a national advisory firm helping innovators navigate the federal funding ecosystem. We support companies and academic institutions across the funding lifecycle, from early-stage strategy through proposal development, negotiations, and post-award execution, ensuring you win the award and deliver the program.
If your institution is looking to capitalize on this shifting landscape, schedule a consultation with our team to discuss how to optimize your funding strategy.
